According to a recent study, tildrakizumab was shown to be efficacious in treating moderate-to-severe plaque psoriasis on the scalp.
Topical treatment improves sleep quality in PsO, AD patients
According to a recent study, topical treatment decreases itch and improves sleep patterns in patients with psoriasis and atopic dermatitis.
Study finds link between skin disorder visibility and stigma
According to a recent study, the visibility of a skin disorder is directly linked to stigma including bullying.
Topical melatonin, rosuvastatin may reduce severity of mild-to-moderate plaque PsO
According to a recent study, topical melatonin and topical rosuvastatin were both effective in reducing the severity of mild-to-moderate plaque psoriasis.
Guselkumab efficacious in PsO patients with history of cancer
According to a recent study, guselkumab is efficacious in patients with moderate-to-severe psoriasis and a history of cancer.
Study shows apremilast effective for moderate-to-severe plaque PsO in pediatric patients
According to a recent study, apremilast is effective for the treatment moderate-to-severe plaque psoriasis short-term in pediatric patients.
Blood monocyte count in PsO patients may predict early response to secukinumab
According to a recent study, plaque psoriasis patients with lower blood monocyte counts at baseline achieved early response and better outcomes when treated with secukinumab.
Guselkumab shows significant scalp psoriasis clearance in skin of colour patients
According to a recent study, guselkumab has shown significant improvements in skin clearance, scalp itch, and patient-reported health-related quality of life in skin of colour patients with moderate-to-severe scalp psoriasis.
Study shows IL-23 inhibitors linked to lowest risk on paradoxical AD in PsO patients
According to a recent study, IL-23 inhibitors used to treat psoriasis patients are associated with the lowest risk of paradoxical atopic dermatitis (AD) compared to other biologics.
Study shows PsO patients with pruritis, sleep disturbances experience lower QoL in all domains
According to a recent study, psoriasis (PsO) patients with pruritis and related sleep disturbances showed a lower quality of life in all domains.
HealthMinute.TV 